06/13/2026
While mitochondrial health is foundational at any age, specific groups benefit most from NIR and antioxidant support:
The "Silver" Demographic (Ages 50+): As patients age, natural cerebrospinal melatonin levels can drop significantly. This group is the primary candidate for NIR therapy to bridge the "defense gap" and mitigate early signs of cognitive decline.
High-Stakes Professionals (Ages 30-50): Individuals facing chronic "indoor" lifestyles and high cognitive workloads often experience mitochondrial strain. Early adoption helps preserve the "Goldilocks zone" of cellular resilience.